Prescription Patterns for Pulmonary Vasodilators in the Treatment of Pulmonary Hypertension Associated With Chronic Lung Diseases: Insights From a Clinician Survey
Background: Pulmonary hypertension is a complication of chronic lung diseases (PH-CLD) associated with significant morbidity and mortality. Management guidelines for PH-CLD emphasize the treatment of the underlying lung disease, but the role of PH-targeted therapy remains controversial. We hypothesi...
Guardado en:
Autores principales: | Christopher A. Thomas, Justin Lee, Roberto J. Bernardo, Ryan J. Anderson, Vladimir Glinskii, Yon K. Sung, Kristina Kudelko, Haley Hedlin, Andrew Sweatt, Steven M. Kawut, Rishi Raj, Roham T. Zamanian, Vinicio de Jesus Perez |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/37a7b37894ae478fa5990c4775f90cae |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evidence base for specific pulmonary vasodilators in adults with congenital heart disease
por: Anton A. Shmalts, et al.
Publicado: (2021) -
Pulmonary artery dissection in long standing idiopathic pulmonary arterial hypertension: A case report
por: Luis Regalado, BS, MSc, et al.
Publicado: (2022) -
Entrenamiento interválico de alta intensidad contribuye a la normalización de la hipertensión arterial
por: Olea,María Angélica, et al.
Publicado: (2017) -
Topical vasodilator response in skeletonized internal mammary artery: Is there really a difference?
por: Syed Raza Shah, et al.
Publicado: (2017) -
Exercise-Induced Pulmonary Hypertension: How to Define, Diagnose, and Treat At-Risk Patients
por: Brandon Shokoples, et al.
Publicado: (2021)